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Conclusion: The results of this study demonstrate that catheter ablation of AF results in
reverse remodeling of both the LA volume as well as the PV orifices.
1071-220 Initial Results of Anatomical Pulmonary Vein Isolation 
for Atrial Fibrillation
Chandrasekhar R. Vasamreddy, Timm Dickfeld, Vinod Jayam, Zayd Eldadah, Lars 
Lickfett, David Bradley, Hugh Calkins, Johns Hopkins School of Medicine, Baltimore, MD
Background: Anatomical pulmonary vein (PV) isolation has recently been described as
an effective ablation strategy for treatment of atrial fibrillation (AF). These results are
mainly based on a large single-center experience and have yet to be validated by other
centers. The purpose of this study was to report our experience with an anatomically
based ablation strategy..
Methods: Twenty consecutive patients (11 men age 56 + 10 years) underwent anatomi-
cal isolation of the PVs guided by a three-dimensional mapping system (CARTO, Bio-
sense). Each patient had symptomatic drug refractory paroxysmal (2 patients), persistent
(6 patients) or permanent (12 patients) AF. MRI was obtained before and 2-month after
ablation to monitor for PV stenosis. Procedure success was assessed at 3-months fol-
low-up using subjective arrhythmia burden, symptoms, ECG, and Holter monitoring.
Results: Baseline MRI showed abnormal PV anatomy in two patients (left common vein
in one and roof vein in the other). Anatomical PV isolation was successfully performed in
all patients without any immediate complications. The average total procedure, antero-
posterior, and lateral fluoro times were 291+62, 67+18, and 64+20 minutes respectively.
Thirteen out of the total 20 patients completed 3-months follow-up. Ten of these 13
patients (77%) were free of AF and on no antiarrhythmic medications. One (8%) had sig-
nificant improvement in AF and two (15%) failed the procedure. Mild pulmonary stenosis
(< 50%) was observed in 2 patients.
Conclusion: Anatomical PV isolation appears to be a safe and effective ablation strategy
in the treatment of AF.
1071-221 Prevalence of Asymptomatic Recurrences of Atrial 
Fibrillation After Successful Radiofrequency Catheter 
Ablation
Srikar Veerareddy, Hakan Oral, Eric Good, Burr Hall, Peter Cheung, Kristina Lemola, 
Jihn Han, Kamala Tamirisa, Aman Chugh, Frank Pelosi, Jr., Fred Morady, University of 
Michigan, Ann Arbor, MI
Background: The long-term efficacy of radiofrequency catheter ablation of atrial fibrilla-
tion (AF) has been based on patient-reported symptoms suggestive of AF. However,
asymptomatic recurrences of AF may remain undetected. The purpose of this study was
to determine the prevalence of asymptomatic recurrences of AF after an apparently suc-
cessful catheter ablation procedure for AF. Methods: Among 211 consecutive patients
(age= 53±11 yrs) with symptomatic paroxysmal AF who underwent a catheter ablation
procedure for paroxysmal AF and who reported no symptoms of recurrent AF, 47 (22%,
age=53±8 yrs) were randomly selected at least 6 month post-procedure. Pre-ablation,
these patients had experienced 17±13 episodes of AF/ month. Patients were provided
with an event recorder for 30 days, a mean of 545±178 days after the ablation procedure.
Patients were asked to record and transmit at least 1 recording per day and also when-
ever they felt palpitations. The rhythms were analyzed by 2 independent investigators.
Results: Seven patients felt palpitations during the study, although they had not had
symptoms previously. Each of these 7 patients had an episodes of AF documented with
the event monitor during symptoms. Among the remaining 40 patients who had no symp-
toms, an episode of AF was captured in 2 (5%) during routine daily monitoring. One of
these patients also had atrial flutter. However, the mean number of episodes per month
was markedly lower(2) after than before the ablation (30). The duration of these episodes
were 1 and 10 min. Conclusions: Asymptomatic recurrences of AF after an apparently
successful catheter ablation procedure for symptomatic paroxysmal AF occur infre-
quently. These asymptomatic episodes appear to be shorter in duration and less frequent
than before the ablation, and may not necessarily exclude a clinically satisfactory out-
come. However, extended monitoring may be necessary to precisely determine the effi-
cacy of ablation procedures for AF.
1071-222 Relationship of Ostial Pulmonary Vein Diameter to 
Hypertension and Left Ventricular Hypertrophy in 
Patients With Atrial Fibrillation
Bengt Herweg, Tina C. Sichrovski, Luiza Petre, Leo Polosajian, Jonathan S. Steinberg, 
St. Luke's Roosevelt Hospital, New York, NY, University of South Florida, Tampa, FL
Background: Increased ostial pulmonary vein (PV) diameter has been reported in
patients with atrial fibrillation (AF). It remains unclear whether increased PV diameter is a
consequence of AF or due to a noncompliant left ventricle. The purpose of this study was
to investigate the relationship between history of hypertension (HTN), and presence of
left ventricular hypertrophy (LVH) relative to ostial PV diameter in patients with AF.
Methods: We measured the ostial diameter of 324 PVs in 100 patients undergoing PV
isolation procedure for AF by intra-cardiac ultrasound (ICUS), PV angiography, and pre-
operative spiral CT. Diameter measurements of all PVs were compared between patients
without HTN or LVH (n=55), with HTN but no LVH (n=34), or with HTN and LVH (n=11) on
2D echocardiogram. Data are displayed as mean±SEM.
Results: summarized in the table (*p<0.02 compared to no HTN or LVH). Ostial diameter
between individual PVs correlated (r=0.24-0.54, p<0.01). Left atrial dilatation was associ-
ated with larger PV diameter by spiral CT (1.54±0.03 vs. 1.46±0.03, p<0.05).
Conclusion: HTN and LVH are associated with increased ostial PV diameter by all imag-
ing modalities in patients with AF, suggesting that clinical conditions that create a non-
compliant left ventricle may facilitate stretch-induced arrhythmogenesis.
1071-223 Ablation of Superior Pulmonary Veins Compared to 
Ablation of All Four Pulmonary Veins: A Randomized 
Clinical Trial
Demosthenes Katritsis, Kenneth Ellenbogen, Demosthenes B. Panagiotakos, Eleftherios 
Giazitzoglou, Elias Karabinos, Anastasios Papadopoulos, Constantinos Zambartas, 
Constantine Anagnostopoulos, Athens Euroclinic, Athens, Greece, Medical College of 
Virginia, Richmond, VA
OBJECTIVES: To compare a superior pulmonary veins (PVs) isolation approach with
isolation of all PVs for the treatmet ofparoxysmal atrial fibrillation (PAF).
BACKGROUND: Isolation of all PVs is advocated for PAF. However, the superior PVs are
responsible for most AF triggers whereas the inferior PVs carry the higher risk for abla-
tion-induced ostial stenosis.
METHODS: Fifty-two patients with PAF were randomized to either LSPV isolation fol-
lowed by additional isolation of the RSPV in case of AF recurrence (group A, n=27) or
isolation of all four PVs followed by a repeat procedure in case of recurrence (group B,
n=25).
RESULTS: Thirteen of the 27 patients (48%) in group A and 8 of 25 patients (32%) in
group B had AF recurrence within 3 months (p = 0.85 ). Five of the patients with AF
relapse in Group A underwent ablation of the RSPV and 4 of them additional re-ablation
of the LSPV, whereas 3 patients with AF relapse in Group B underwent a repeat proce-
dure. At 1 year follow-up, 11 patients (41%) in Group A and 8 patients (32%) in Group B
had AF relapse (p = 0.55). No significant differences in AF relapse were detected
between groups at 3 and 12 months (log-rank=0.36, p = 0.54) and by Cox-proportional
hazards model analysis (p=0.62). Non-significant PV stenosis was detected in 2 patients
of group B. Total radiofrequency energy delivery, and fluoroscopy and procedure time
were lower in group A: 8.9±1.4 min vs 25.6±3.7 min (p<0.001), 22.2±6.8 min vs 62±10.3
min (p<0.001), and 131.8±26.5 min vs 222.2±32.3 min (p<0.001), respectively.
CONCLUSIONS: A staged PVs isolation approach by targeting the LSPV and RSPV
confers equal success rates but with reduced radiofrequency energy delivery, and fluo-
roscopy and procedure time compared to isolation of all PVs at the initial ablation
attempt.
1071-224 Percutaneous Cryothermic Pulmonary Vein Isolation for 
the Treatment of Atrial Fibrillation: Impact of Specific 
Catheter Design
Tom Wong, Vias Markides, Nicholas S. Peters, D. Wyn Davies, St. Mary's Hospital and 
Imperial College, London, United Kingdom
Background
Conventional ablation catheters were originally designed to generate lesion to destroy a
localized substrate such as in the Wolf-Parkinson-White syndrome. Creating segmental
or circumferential lesions using such catheter can be cumbersome. We therefore exam-
ined the impact of evolving cryoablation catheter design on the feasibility, efficacy, and
safety of pulmonary vein (PV) isolation using cryoablation.
Methods
We performed 60 PV isolation procedures in 51pts (23M, 54.7±10.4 yrs) with symptom-
atic drug refractory paroxysmal (43pts), or persistent (8pts) AF, using conventionally
designed catheters either with a 4mm-tip (Freezor™, n=27, group 1), or a 6mm-tip (Free-
PV Diameter (cm)
no HTN or LVH
(n=55)
HTN but no LVH
(n=34)
HTN and LVH
(n=11)
ICUS 1.56 ± 0.04 1.80 ± 0.06* 1.91 ± 0.13* p<0.001
Angiogram 1.67 ± 0.04 1.81 ± 0.06* 2.10 ± 0.16* p<0.01
Spiral CT 1.43 ± 0.02 1.55 ± 0.03* 1.59 ± 0.06* p<0.01
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zor Xtra™, n=10, group 2), and a specifically designed curvilinear-tipped (Artic Circler™,
n=23, group 3) catheter. In 10 group 3 procedures, additional cryoablation lesions were
created using a 6mm-tipped catheter to complete the PV isolation. A total of 94 PVs were
treated. Pulmonary venograms were performed before and immediately after ablation.
Results
In total, 78% (74/94) PVs were isolated successfully; 21/33 (64%) in group 1, 11/12
(92%) in group 2, and 42/49 (86%) in group 3. The cryoablation time required for isolation
of each PV in group 3 was significantly shorter that for groups 1 and 2 (31±30 vs.
66±37min for group 1, and 77±45min for group 2, p<0.001). Thus more PVs were treated
during a single procedure in this group (2.1 ± 0.9 vs. 1.2 ± 0.4 for each of groups 1 and 2,
p<0.01), with similar procedural duration (288±91 vs. 316±109 and 243±81min, p=NS).
The PV diameters remained unchanged immediately after cryo-ablation in all patients,
and 8.8±5.4months after cryoablation in 30 treated PVs of 20pts who returned for further
procedures. During a follow up period of 4.1±4.6 months, 12/24 pts (50%) in group 1, 3/
10 pts (30%) in group 2, and 17/22 pts (77%) in group 3 were either free from AF or had
a significant reduction in AF burden as assessed by symptoms and 24 hour tapes.
Conclusion
Percutaneous cryothermic PV ablation is feasible and safe, and is facilitated by a specific
designed curvilinear self-expanding cryoablation catheter.
1071-225 Modes of Failure in Pulmonary Vein Isolation With 
Circumferential Laser Energy Ablation
Wilber Su, Susan B. Johnson, Douglas L. Packer, Mayo Clinic, Rochester, MN
BACKGROUND:Pulmonary vein (PV) isolation using balloon devices in the treatment of
atrial fibrillation has had limited success. Initial animal trials specifically using a circumfer-
ential laser energy balloon have been promising, but the modes of failure are unclear.
METHODS: To assess the cause of incomplete PV isolation following circumferential
laser energy delivery, 54 PV lesions were created in 30 dogs. Intracardiac ultrasound
(ICUS) and fluoroscopy were used to assess positioning and seating of the ablation bal-
loon. Laser energy was delivered at 3.5, 4.5, or 5.5 W/cm for 120 to 600 seconds. Abla-
tion end-points were defined as either complete electrical isolation of the PV or a total
ablative time of 600 seconds.
RESULTS: Acute entrance block was achieved in 34 of 54 PVs (63%). Of the remaining
20 PVs (37%) without block, incomplete circumferential ablation in 15 PVs was related to
an inadequate balloon-to-PV-orifice seal as confirmed by intracardiac ultrasound. Signifi-
cant blood flow leaks were localized to the inferior aspect of the LSPV (12/15 PVs) and
the inferior aspect of the RSPV (3/15 PVs). In the remaining 5 PVs with failure to block
despite complete balloon-to-PV-orifice seals, early branching of the PV, seen at the abla-
tion site, disrupted the intended circumferential laser ring.
CONCLUSIONS: Laser energy balloon ablation devices can successfully create circum-
ferential PV isolation. Failure to produce appropriate lesions is due to gaps in circumfer-
ential block that are most often secondary to incomplete balloon-tissue seals readily
identifiable by ICUS. Anatomic variations in the PVs also result in incomplete circumfer-
ential lesions at the balloon-tissue interface.
1071-226 Subclinical Pulmonary Vein Narrowing Is Common 
Following Atrial Fibrillation Ablation
Thomas H. Hauser, Susan B. Yeon, Seth McClennen, George Katsimaglis, Kraig V. 
Kissinger, Mark E. Josephson, Neil M. Rofsky, Warren J. Manning, Beth Israel 
Deaconess Medical Center, Boston, MA, Harvard Medical School, Boston, MA
Background: Radiofrequency ablation (RFA) for the treatment of atrial fibrillation (AF) is
increasingly performed. While clinical pulmonary vein (PV) stenosis is a rare complica-
tion of these procedures, subclinical narrowing may be more common. We assessed
potential changes in PV size following AF ablation using contrasted enhanced 3D mag-
netic resonance angiography (MRA).
Methods: Maximal PV diameter, circumference and cross-sectional area (CSA) were
measured in a group of consecutive patients who underwent PV MRA before and 1.3
months after their first AF ablation. The number and duration of RFA during the index pro-
cedure were also recorded.
Results: There were a total of 86 PV in 23 patients (20 [87%] men, age 54 ± 11 years).
There were significant decreases in maximal PV diameter (21 ± 6 to 19 ± 5 mm), circum-
ference (57 ± 14 to 52 ± 13 mm) and CSA (236 ± 118 to 194 ± 92 mm2; p < 0.001 for all)
from baseline to follow-up studies. No PV diameter reduction of >50% was seen,
although 7 (8%) PV had a diameter reduction of >25% and <50%. In comparison, 9
(11%) PV had a >50% CSA reduction and 16 (19%) PV had a 25% to 49% CSA reduc-
tion. The reduction in PV size was not related to either the number of RFA per PV
(median = 8) or the RFA duration (median = 210 s, p > 0.1 for all measures of PV size).
Conclusions: Although clinical PV stenosis is rare, subclinical PV narrowing is common
after RFA for the treatment of AF with the greatest reduction in CSA. The severity of PV
narrowing appears unrelated to the intensity of RFA and may be related to absence of AF
and/or hemodynamic changes such as decreased left atrial pressure.
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1072-209 PR Interval Prolongation but Not QRS Widening Is an 
Independent Factor of Functional Intolerance in Heart 
Failure Patients With Dilated Cardiomyopathy
Axel Champagne de la Briolle, Christophe Leclercq, Veronique Sebille, Francois Carre, 
Christian de Place, Philippe Mabo, Jean-Claude Daubert, University Hospital Rennes, r, 
France
Background: The aim of this cohort study was to assess whether electrical conduction
abnormalities and electromechanical correlates may independently affect symptoms and
exercise tolerance in patients with dilated cardiomyopathy (DCM) and chronic heart fail-
ure (CHF).
Methods and results: 103 consecutive patients with stable CHF and optimized drug
treatment, and echochardiographic evidence of LV ejection fraction (LVEF) <40% and LV
end-diastolic diameter (LVEDD) >60mm, were included and prospectively assessed by
12-lead surface ECG, Doppler-echocardiography to measure pre-ejection, ejection and
post-ejection electromechanical intervals, cardiopulmonary exercise testing, radionu-
clides angiocardiography and coronary angiography, all performed within a maximal time
interval of 24 hr. LVEF (radionuclides) and LVEDD (echo) were on average 26+9% and
71+8 mm, respectively. Mean PR and QRS intervals duration were 191+43 ms and
139+39 ms, respectively. PR >200ms and QRS >120ms were observed in 36% and 60%
of cases, respectively. Coronary angiography was normal in 86% pts.
Univariate analysis showed that the longer was PR interval, higher was NYHA class
(p<0.001) and lower were exercise duration (p<0.001) and peak VO2 (p<0.01). Signifi-
cant but weaker correlation were found for QRS duration with NYHA class (p<0.01) and
exercise time (p<0.02). Decrease in pulmonary and aortic ejection times, and in isovolu-
mic relaxation time (IVRT) were associated with higher NYHA class and lower peak VO2.
No significant correlation was observed for any pre-ejection parameter.
In multivariate analysis, PR prolongation and shortening in ejection times and/or IVRT
were shown to be predictive of higher NYHA class and poorer exercise tolerance inde-
pendently of baseline LVEF and LVEDD. QRS widening did not appear as independent
predictor of decreased exercise tolerance.
Conclusion: Within the limitations of this type of study, PR interval prolongation but not
QRS widening is an independent predictive factor of functional deterioration in CHF
patients with DCM.
1072-210 The Prognostic Significance of Right Bundle Branch 
Block Associated With Additional Conduction 
Abnormalities
Patrick Yue, Takuya Yamazaki, Vikram Aleti, Anima Mathur, Kyaw K. Soe, Victor 
Froelicher, Palo Alto Veterans Affairs Health Care System, Palo Alto, CA, Stanford 
University Medical Center, Stanford, CA
Background: The prognostic significance of right bundle branch block (RBBB) in a vari-
ety of clinical settings is well known, but there is little data regarding the natural history of
RBBB associated with other conduction abnormalities.
Methods: We analyzed index electrocardiograms (ECGs) on 46,933 subjects obtained at
a single institution between 1987 and 2000. After excluding a prior history of pacemaker
(PM) implantation, 1,675 subjects (mean age 69 ± 11) were found to have a RBBB.
ECGs were assessed for left or right axis deviation and atrioventricular (AV) conduction
delay. The main outcome measures were cardiovascular (CV) mortality and PM implan-
tation.
